We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.1B
AUM Growth
+$134M
Cap. Flow
-$3.91B
Cap. Flow %
-25.89%
Top 10 Hldgs %
18.53%
Holding
722
New
62
Increased
243
Reduced
170
Closed
71

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$92.3M
2
MSFT icon
Microsoft
MSFT
+$73.7M
3
XOM icon
ExxonMobil
XOM
+$73.7M
4
SBUX icon
Starbucks
SBUX
+$72.3M
5
PG icon
Procter & Gamble
PG
+$54M

Sector Composition

Rank Sector Weight
1 Financials 12.08%
2 Technology 11.12%
3 Healthcare 9.42%
4 Consumer Discretionary 8.48%
5 Industrials 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
176
DELISTED
Allergan plc
AGN
$9.46M 0.06%
36,756
+191
+0.5% +$47.7K
UNH icon
177
UnitedHealth
UNH
$382B
$9.31M 0.06%
92,078
+478
+0.5% +$45.3K
MMM icon
178
3M
MMM
$89B
$9.07M 0.06%
66,002
+342
+0.5% +$43.9K
PRU icon
179
Prudential Financial
PRU
$41.7B
$9M 0.06%
99,472
-38,340
-28% -$3.29M
ESRX
180
DELISTED
Express Scripts Holding Company
ESRX
$8.93M 0.06%
105,447
-24,453
-19% -$1.91M
NEE icon
181
NextEra Energy
NEE
$187B
$8.8M 0.06%
331,320
+1,720
+0.5% +$43.4K
KMI icon
182
Kinder Morgan
KMI
$73.1B
$8.57M 0.06%
202,617
+165,817
+451% +$6.53M
SO icon
183
Southern Company
SO
$110B
$8.56M 0.06%
174,405
+905
+0.5% +$42.7K
DTV
184
DELISTED
DIRECTV COM STK (DE)
DTV
$8.45M 0.06%
97,506
+506
+0.5% +$43.5K
AGN
185
DELISTED
Allergan Inc
AGN
$8.29M 0.05%
39,002
+202
+0.5% +$40.2K
PNC icon
186
PNC Financial Services
PNC
$100B
$8.25M 0.05%
90,470
-25,995
-22% -$2.25M
SKM icon
187
SK Telecom
SKM
$13.7B
$8.15M 0.05%
183,180
+1,214
+0.7% +$56.4K
SPG icon
188
Simon Property Group
SPG
$74.5B
$8.09M 0.05%
44,431
+231
+0.5% +$41K
SPY icon
189
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$8.07M 0.05%
+39,280
New +$7.9M
ST icon
190
Sensata Technologies
ST
$6.65B
$7.97M 0.05%
152,111
-207,271
-58% -$10.1M
DD
191
DELISTED
Du Pont De Nemours E I
DD
$7.85M 0.05%
111,777
+580
+0.5% +$38.8K
OEF icon
192
PUT
iShares S&P 100 ETF
OEF
$19.8B
$7.7M 0.05%
5,624
+674
+14% +$60.3K
BAP icon
193
Credicorp
BAP
$30.9B
$7.69M 0.05%
48,025
-27,945
-37% -$4.44M
VTRS icon
194
Viatris
VTRS
$20.1B
$7.66M 0.05%
135,848
-21,322
-14% -$1.14M
TWX
195
DELISTED
Time Warner Inc
TWX
$7.57M 0.05%
88,657
-96,990
-52% -$7.73M
KLXI
196
DELISTED
KLX Inc.
KLXI
$7.56M 0.05%
+217,427
New +$7.65M
PCP
197
DELISTED
PRECISION CASTPARTS CORP
PCP
$7.55M 0.05%
31,363
+163
+0.5% +$37.6K
ALXN
198
DELISTED
Alexion Pharmaceuticals
ALXN
$7.44M 0.05%
40,209
+209
+0.5% +$38.7K
BCR
199
DELISTED
CR Bard Inc.
BCR
$7.35M 0.05%
+44,130
New +$7.14M
GM icon
200
General Motors
GM
$74.7B
$7.18M 0.05%
205,579
+3,193
+2% +$102K

Similar funds

Calamos Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Calamos Advisors held 722 positions worth $15.1B, up 0.89% from $15B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Calamos Advisors withdrew a net $3.91B in Q4 2014, closing 71 positions and reducing 170 holdings. Its most notable exit was METLIFE, INC. COM EQUITY UNIT, an estimated $130M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Calamos Advisors opened a new position in Northrop Grumman worth $29.4M.

  • Calamos Advisors's largest Q4 2014 buy was Northrop Grumman: 199,438 shares worth $29.4M.
  • Calamos Advisors added most to MetLife in Q4 2014, an estimated $92.3M increase.
  • Calamos Advisors's biggest Q4 2014 reduction was SLB Ltd, cutting an estimated $108M.
  • Calamos Advisors fully exited METLIFE, INC. COM EQUITY UNIT in Q4 2014, selling an estimated $130M.
  • Calamos Advisors's ten largest holdings make up 19% of its $15.1B portfolio in Q4 2014.
  • Calamos Advisors opened 62 new positions and closed 71 in Q4 2014.
  • Calamos Advisors's portfolio value rose 0.89% quarter-over-quarter to $15.1B.

Based on Calamos Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.